BCHE and Alzheimer disease: Finally, clinical guidelines25, 26 recommend trial of a cholinesterase inhibiting medicine or memantine for all people with mild to moderately-severe Alzheimer’s disease (AD) because these medicines can slow the progression of cognitive impairment in some cases27.